We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
+11.62%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
–
AUM
$11.1B
AUM Growth
+$2.91B
Cap. Flow
+$2.44B
Cap. Flow %
22.01%
Top 10 Hldgs %
80.14%
Holding
1,432
New
428
Increased
273
Reduced
246
Closed
471

Top Buys

Rank Stock Value
1
WDAY icon
Workday
WDAY
+$31.9M
2
CME icon
CME Group
CME
+$21.5M
3
PXD
Pioneer Natural Resource Co.
PXD
+$19.5M
4
SMH icon
VanEck Semiconductor ETF
SMH
+$17M
5
KKR icon
KKR & Co
KKR
+$16.5M

Top Sells

Rank Stock Value
1
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$111M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$38.6M
3
HD icon
Home Depot
HD
+$14.9M
4
SPIB icon
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
+$11.5M
5
NVDA icon
NVIDIA
NVDA
+$9.91M

Sector Composition

Rank Sector Weight
1 Technology 2.19%
2 Financials 1.49%
3 Industrials 1.31%
4 Consumer Discretionary 0.86%
5 Energy 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LNAI
901
Lunai Bioworks
LNAI
$10.7M
$86.5K ﹤0.01%
+408
New +$110K
CRCT icon
902
Cricut
CRCT
$1.24B
$86.1K ﹤0.01%
+18,090
New +$96.4K
SYRS
903
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$85.8K ﹤0.01%
+16,036
New +$111K
NVTS icon
904
Navitas Semiconductor
NVTS
$3.44B
$84.6K ﹤0.01%
17,737
+6,607
+59% +$38.8K
AVIR icon
905
Atea Pharmaceuticals
AVIR
$402M
$84.1K ﹤0.01%
20,809
-4,908
-19% -$19.2K
SCLX icon
906
Scilex Holding
SCLX
$47.1M
$83.9K ﹤0.01%
+1,508
New +$87.9K
MFIN icon
907
Medallion Financial
MFIN
$249M
$82.2K ﹤0.01%
+10,393
New +$93.4K
MAMA icon
908
Mama's Creations
MAMA
$822M
$79.8K ﹤0.01%
+15,968
New +$75.6K
LUNR icon
909
Intuitive Machines
LUNR
$2.53B
$78.4K ﹤0.01%
+12,547
New +$59.6K
AMRX icon
910
Amneal Pharmaceuticals
AMRX
$5.71B
$77.7K ﹤0.01%
12,817
-35,887
-74% -$202K
NXDR
911
Nextdoor Holdings
NXDR
$1.04B
$76.7K ﹤0.01%
34,101
+891
+3% +$1.67K
LTRX icon
912
Lantronix
LTRX
$256M
$76.6K ﹤0.01%
+21,525
New +$106K
SSP icon
913
E.W. Scripps
SSP
$309M
$76.6K ﹤0.01%
+19,483
New +$117K
AQST icon
914
Aquestive Therapeutics
AQST
$538M
$76.5K ﹤0.01%
+17,965
New +$59.8K
VNDA icon
915
Vanda Pharmaceuticals
VNDA
$304M
$75.2K ﹤0.01%
18,288
-7,383
-29% -$29.6K
CTOS icon
916
Custom Truck One Source
CTOS
$2.42B
$74.5K ﹤0.01%
12,793
+1,011
+9% +$6.28K
CBIO
917
Crescent Biopharma
CBIO
$644M
$70K ﹤0.01%
+233
New +$69.6K
RLMD icon
918
Relmada Therapeutics
RLMD
$484M
$69.4K ﹤0.01%
+14,918
New +$71.9K
CVAC
919
DELISTED
CureVac
CVAC
$68.9K ﹤0.01%
22,738
+8,633
+61% +$30.3K
YEXT icon
920
Yext
YEXT
$577M
$68.3K ﹤0.01%
11,321
-10,220
-47% -$60.4K
LPRO
921
DELISTED
Open Lending Corp
LPRO
$66.7K ﹤0.01%
10,650
-12,101
-53% -$89.3K
BKD icon
922
Brookdale Senior Living
BKD
$3.27B
$66.6K ﹤0.01%
10,070
-12,953
-56% -$75.6K
CNSL
923
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$64.4K ﹤0.01%
+14,914
New +$64.9K
BCRX icon
924
BioCryst Pharmaceuticals
BCRX
$2.51B
$63.5K ﹤0.01%
12,499
-57,592
-82% -$324K
RYAM icon
925
Rayonier Advanced Materials
RYAM
$593M
$60.8K ﹤0.01%
12,718
-20,898
-62% -$88.9K
35 36
37
38 39

Similar funds

GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
DWM
Dynasty Wealth Management St. Petersburg, Florida $11.5B AUM 15.23% 1-Year Est. Return
HTC
Haverford Trust Company Radnor, Pennsylvania $10.9B AUM 18.64% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Brevan Howard Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Brevan Howard Capital Management held 1,432 positions worth $11.1B, up 36% from $8.18B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Brevan Howard Capital Management deployed $2.44B of net new capital in Q1 2024, opening 428 new positions and adding to 273 existing holdings. Its largest new stake was CME Group: 102,553 shares worth $22.1M.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 1.7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Home Depot, an estimated $14.9M trimmed.

  • Brevan Howard Capital Management's largest Q1 2024 buy was CME Group: 102,553 shares worth $22.1M.
  • Brevan Howard Capital Management added most to Workday in Q1 2024, an estimated $31.9M increase.
  • Brevan Howard Capital Management's biggest Q1 2024 reduction was Home Depot, cutting an estimated $14.9M.
  • Brevan Howard Capital Management fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $111M.
  • Brevan Howard Capital Management's ten largest holdings make up 80% of its $11.1B portfolio in Q1 2024.
  • Brevan Howard Capital Management opened 428 new positions and closed 471 in Q1 2024.
  • Brevan Howard Capital Management's portfolio value rose 36% quarter-over-quarter to $11.1B.

Based on Brevan Howard Capital Management's 13F filing for Q1 2024, filed 15 May 2024.